About Me

Tushar Tomar was born on the 28th of October 1987 in Punjab, India. He completed his higher secondary school education in 2005 specializing in biology, chemistry, physics and mathematics. He completed his bachelors in pharmacy from prestigious Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), University of Delhi, India. During his studies, he participated in an external research project on 'Probiotics and their role in promoting human health' under supervision of Prof. Dr. Anil Puniya at National Diary research institute, India.

In 2009, Tushar awarded a full scholarship (covering tuition fee and living expenses) for pursuing his masters in Medical and Pharmaceutical Sciences, at the University of Groningen, The Netherlands. Taking advantage of research module of master studies with two research projects, he conducted his first research project on investigating the high fat-diet effects on renal endothelial dysfunction in Human CRP transgenic (hCRPtg) mice under the supervision of Prof. Peter Heeringa at Department of Pathology and Medical Biology, University Medical Centre Groningen (UMCG). In his second research project, Tushar worked on tumor-stromal targeting of Interferon gamma and studied its anti-tumor and angiogenetic effects under supervision of Dr. Jai Prakash and Prof. Klaas Poelstra at Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen. After developing keen interest in cancer research, Tushar decided to continue his career in research as PhD scholar. In August 2011 he defended his master's thesis and in September 2011, he joined the Department of Gynecologic Oncology of UMCG and conducted his PhD research under the supervision of Prof. Steven de Jong, Prof. Ate van der Zee and Dr. Bea Wisman. His main research focused on (Epi)genomic characterization of chemotherapy response in ovarian cancer. During his PhD tenure he awarded many departmental personal research grants, several invited talks and prestigious European Association of Cancer Research (EACR) Proffered Paper Award 2014 at Munich, Germany. He also established over fifty patient-derived mouse models for ovarian cancer for different histological subtypes which is now part of European consortium EUROPDX(http://www.europdx.eu/). Currently, Tushar is a Postdoctoral research fellow at Medical Oncology department of UMCG under supervision of Prof. Frank Kruyt and Prof. Steven de Jong, where he is targeting the breast cancer stem-like cells using novel after using novel therapeutic strategies.

  • Cancer biologist with training in translational medicine research focusing on genomics and epigenomics of drug-resistance in gynecological cancers
  • Experienced in various omics data analysis including whole (epi)genomics (transcriptomics, SNP, Methylation, NGS) of primary patient material as well as wet lab work that covers functional validation with in-vitro (tumor cell lines) and in-vivo (various xenograft (PDX) mouse models) setting
  • Involved in several multidisciplinary research projects with successful completion
  • Keen interest in targeting tumor microenvironment (including immune system) to treat cancer as my future research work
  • Self-motivated, organized and passionate about research and making an impact
  • Open to new research challenges, strive for achieving goals and learning new skills if required